What is Cutaneous Histiocytoma in Dogs?

A cutaneous histiocytoma is a benign skin tumor that arises from Langerhans cells, a type of immune cell in the skin. It shows up most often in young dogs, grows alarmingly fast, and then, in most cases, disappears on its own without any treatment at all.

That last part is what makes it one of the strangest tumors in veterinary medicine. A histiocytoma is a genuine tumor. It is also a tumor the dog's own immune system usually recognizes and destroys.

If your veterinarian has just used this word about a lump on your dog, this article explains what it is, why it behaves the way it does, how it is diagnosed, and the specific situations in which it needs to come off.

The Cell Behind the Name

Histiocyte is a general term covering several related immune cell types that reside in tissue. The one that gives rise to cutaneous histiocytoma is the Langerhans cell, a specialized antigen-presenting cell whose normal job is patrolling the skin for foreign material and presenting it to the rest of the immune system.

Strong immunohistochemical evidence supports the Langerhans cell origin of these tumors (Villalobos, 2026). Exactly which Langerhans cell is the starting point is less settled. Merck describes derivation from intraepidermal Langerhans cells (Villalobos, 2026), while the UC Davis histiocytosis group holds that histiocytomas do not arise directly from intraepidermal Langerhans cells and instead develop from dermal precursors, possibly perivascular CD14 positive precursor cells (Gardiner, n.d.).

For owners, the practical translation is this: the tumor is made of immune cells that have started dividing when they should not have. It is not made of skin cells, glandular cells, or connective tissue. That origin explains almost everything unusual about how it behaves.

What a Histiocytoma Looks Like

The classic presentation is distinctive enough that experienced veterinarians often suspect it on sight.

Lesions are typically solitary, smooth, pink, raised nodules covered by hairless skin, and they are freely movable rather than fixed to underlying tissue (Villalobos, 2026). They are often described as small, hairless, and erythematous, meaning reddened (Torres, 2025). Many ulcerate.

The nickname "button tumor" comes from that discrete, raised, nodular appearance (Mouser, n.d.), and it is a good description. A histiocytoma tends to look like a small pink button someone stuck onto the dog.

The head, including the ear flaps, and the limbs are the most common sites (Villalobos, 2026). Torres (2025) lists lesions as localized to the head, pinna, neck, or limbs.

Which Dogs Get Them

Histiocytoma is strongly associated with young dogs. Most affected dogs are under three years old (Williams et al., n.d.; Torres, 2025), and the Merck Veterinary Manual places the typical range at younger than three and a half years while noting that any age is possible (Villalobos, 2026). In one 2024 study restricted to dogs four years and under, the mean age at surgical excision was 1.84 years (Diehl & Hansmann, 2024).

There is a caveat worth understanding, along with the reason for it. In one referral hospital's surgical case population, histiocytoma patients ranged from 1 to 12 years of age with a median of 6 (Mouser, n.d.). That same source explains why its numbers skew older: histiocytomas are frequently handled by primary care veterinarians and therefore reach a referral surgery service less often, and the source still describes the tumor as generally considered a lesion of young dogs (Mouser, n.d.).

The takeaway is not that the young-dog association is wrong. It is that "young dog tumor" is a strong tendency rather than a rule, and an older dog's lump should not be dismissed as too-old-to-be-a-histiocytoma any more than a young dog's lump should be assumed to be one.

Breed predispositions have been reported, though the specific lists vary between sources. Boxers, Dachshunds, Cocker Spaniels, Great Danes, Bull Terriers, and Shetland Sheepdogs have been described as overrepresented (Torres, 2025). English Bulldogs, Scottish Terriers, Greyhounds, Boxers, and Boston Terriers have also been identified as increased-risk breeds (Villalobos, 2026). Boxers appear on both lists.

The Growth Pattern That Frightens Owners

Here is the sequence that sends people to the emergency clinic.

A histiocytoma grows rapidly during its first one to four weeks (Williams et al., n.d.). It can go from nothing to a visible, angry-looking nodule in a matter of days. Then it frequently ulcerates, which looks even worse. Then it regresses.

Speed of growth is one of the instincts owners rely on to judge whether a lump is dangerous, and with histiocytoma that instinct points the wrong direction. Rapid growth is characteristic of this benign tumor. It is not, on its own, evidence of malignancy.

Reported regression timelines cluster within a few months but differ slightly by source. Solitary nodules often resolve within one to three months and typically ulcerate before resolving (Torres, 2025). Merck reports that most resolve spontaneously within two to three months (Villalobos, 2026). VCA describes many regressing over a few months (Williams et al., n.d.).

Why It Disappears: The Immune System Wins

A tumor that eliminates itself is an unusual thing. In cutaneous histiocytoma it is the norm, and the leading explanation involves the dog's own immune system.

Regressing lesions become infiltrated by lymphocytes that are highly enriched for CD8 positive T cells, and these lymphocytes are thought to mediate lysis of the neoplastic histiocytes (Gardiner, n.d.). In plain terms, the dog's own killer T cells appear to move in and destroy the tumor.

The word "thought" is doing real work in that sentence. The lymphocyte enrichment is demonstrated. The causal step is inferred, and the trigger remains genuinely unknown: no etiology or trigger has yet been identified for either the tumor's development or the start of its regression (Diehl & Hansmann, 2024). Research into the immune checkpoint regulation involved is ongoing.

Under the microscope, this shows up as a prominent lymphocytic infiltrate in late regressing lesions (Torres, 2025). Pathologists sometimes find regressing histiocytomas nearly indistinguishable from ordinary mononuclear inflammation (Mouser, n.d.), because at that stage the sample is more immune response than tumor.

This mechanism has a direct clinical consequence, covered below, that matters more than any other single point in this article.

How Histiocytoma Is Diagnosed

Appearance alone is suggestive but not sufficient. Histiocytoma belongs to a group called round cell tumors, which also includes mast cell tumors, plasma cell tumors, lymphoma, and histiocytic sarcoma (Mouser, n.d.). Some of these are benign and some are decidedly not, and several can look similar to the naked eye. Histiocytomas resemble plasma cell tumors on gross appearance (Mouser, n.d.).

Diagnosis can often be made by cytologic evaluation (Villalobos, 2026), which in practice usually means a fine needle aspirate. Fine needle aspirates and impression smears can be valuable to the pathologist because cytologic preparations may retain cellular detail in better quality (Mouser, n.d.).

When biopsy is performed, characteristic histologic features include a degree of epitheliotropism, meaning the tumor cells interact with the overlying epidermis, and a "top heavy" distribution in which cellularity is greatest near the skin surface. Mitotic indices may be high, and late regressing lesions carry that prominent lymphocytic infiltrate (Torres, 2025).

That last detail is worth pausing on. A high mitotic count, meaning cells dividing rapidly, is usually a red flag. Torres (2025) notes potentially high mitotic indices in this benign tumor, which is one more reason interpretation belongs with a pathologist rather than with pattern-matching from a photograph.

What Else the Lump Could Be

The differentials that matter most are the other round cell tumors. A mast cell tumor is the one no owner wants to miss, and mast cell tumors do occur in young dogs: one 2026 analysis examined 924 cutaneous mast cell tumors in dogs three years and under, including 149 dogs one year old or younger (Schwinn et al., 2026). Plasma cell tumors, cutaneous lymphoma, and histiocytic sarcoma round out the group (Mouser, n.d.).

This is the entire argument for having the lump aspirated rather than watched. The wait-and-see approach works beautifully if the lump is a histiocytoma and poorly if it is something else, and the two situations are not reliably distinguishable by eye.

Treatment: When to Wait and When to Remove

For most solitary histiocytomas in most dogs, the answer is observation. Surgical excision is optional once the diagnosis has been established (Villalobos, 2026), precisely because the immune system is expected to handle it.

Removal becomes appropriate in specific circumstances. VCA advises surgery when ulceration, bleeding, or infection cannot be treated, or when the mass does not shrink within one to two months (Williams et al., n.d.). Torres (2025) sets a longer threshold, recommending removal for lesions that fail to regress within six months or that become infected. In most cases, surgical removal is a permanent cure (Williams et al., n.d.).

The gap between a one-to-two-month threshold and a six-month one is worth raising with your own veterinarian rather than resolving from an article. Location matters, as does whether the dog is traumatizing the site, and a lesion on an ear flap that the dog scratches raw is a different management problem from a quiet nodule on the flank.

The Immunosuppression Warning

This is the most practically important point in the article.

Because regression depends on a CD8 positive cytotoxic T lymphocyte response, immunosuppressive drugs interfere with the immune reaction that clears the tumor, and their use is advised against (Torres, 2025).

Steroids are a common reflex for an angry-looking, inflamed skin lesion. In the case of histiocytoma, suppressing the immune response works directly against the process that would otherwise cure it. If your dog has a suspected or confirmed histiocytoma and any medication is being considered for the site, this is a reasonable and specific question to raise with your veterinarian.

Multiple Histiocytomas and the Shar Pei Exception

Occasionally a dog develops not one histiocytoma but many. This occurs in fewer than 1% of cases and is more prevalent in Shar Peis, and it constitutes cutaneous Langerhans cell histiocytosis rather than ordinary histiocytoma. Shar Peis account for approximately 20% of cutaneous Langerhans cell histiocytosis cases. This form can present with literally hundreds of cutaneous lesions and may progress to systemic disease, with peripheral lymph nodes and lungs consistently affected. Outcomes are considerably worse, and roughly half of affected dogs were euthanized because of the difficulty of managing extensive ulcerated lesions (Gardiner, n.d.).

Treatment data for this form are limited and the reported results are sobering. Cyclosporine A produced no response, and while chemotherapy was effective in most instances, the responses were not durable. One dog treated with griseofulvin responded initially but died after developing systemic disease three months after the drug was withdrawn (Gardiner, n.d.).

This is a genuinely different disease from the single button tumor on a one-year-old Labrador, and it is worth knowing the distinction exists. It is also rare, and a dog with one histiocytoma is overwhelmingly unlikely to be facing it.

Prognosis

For solitary cutaneous histiocytoma, the outlook is excellent. These tumors have benign biological behavior (Mouser, n.d.). Most resolve without intervention within a few months, and excision is a permanent cure in most cases when it is needed (Williams et al., n.d.).

When to Call Your Veterinarian

Any new lump on your dog warrants an appointment, including one you strongly suspect is a histiocytoma. Beyond that initial visit, call again if the lesion is still present beyond the timeframe your veterinarian gave you, if it ulcerates and will not heal, if it bleeds repeatedly or becomes infected, if your dog is chewing or scratching at it, or if new nodules appear elsewhere on the body.

Frequently Asked Questions

Is a histiocytoma cancer? It is a tumor, meaning an abnormal growth of cells, and the solitary form is benign in its biological behavior and usually regresses on its own (Mouser, n.d.; Villalobos, 2026). The rare multicentric form discussed above behaves differently and can progress systemically (Gardiner, n.d.).

How long does a histiocytoma take to go away? Most resolve within one to three months (Torres, 2025), with Merck reporting two to three months as typical (Villalobos, 2026). Ulceration before resolution is common and expected.

Does a histiocytoma need to be removed? Usually not. Excision is optional once the diagnosis is confirmed (Villalobos, 2026), and is reserved for lesions that will not regress, that become infected, or that ulcerate or bleed in ways that cannot be managed (Williams et al., n.d.; Torres, 2025).

My dog is seven. Can it still be a histiocytoma? Yes. The tumor is generally considered a lesion of young dogs, but cases have been reported across a range from 1 to 12 years (Mouser, n.d.), and Merck notes it can be seen at any age (Villalobos, 2026). Age makes it less likely, not impossible, which is why diagnosis rests on cytology rather than on the dog's birthday.

Can a histiocytoma come back? In most cases, surgical removal is a permanent cure for the excised lesion (Williams et al., n.d.). A dog can develop a separate histiocytoma elsewhere, and multiple lesions warrant a conversation about the rarer multicentric form.

The Bottom Line

Cutaneous histiocytoma is a benign Langerhans cell tumor that mostly affects young dogs, grows fast enough to frighten anyone watching, and is usually eliminated by the dog's own immune system within a few months.

The two things worth holding onto: get the lump identified rather than assuming, because the tumors it can be confused with are not all benign, and be cautious about immunosuppressive treatment at the site, because the immune response is what cures it.

This article is provided for educational purposes only and does not constitute veterinary medical advice, diagnosis, or treatment. Always consult a licensed veterinarian regarding the health of your dog. If you notice a new or changing lump on your dog, contact your veterinarian promptly.

References

Diehl, B., & Hansmann, F. (2024). Immune checkpoint regulation is critically involved in canine cutaneous histiocytoma regression. Frontiers in Veterinary Science, 11, Article 1371931. https://doi.org/10.3389/fvets.2024.1371931

Gardiner, J. (n.d.). Histiocytoma complex. University of California, Davis, School of Veterinary Medicine. https://www.histiocytosis.ucdavis.edu/histiocytosis/histiocytoma-complex

Mouser, P. (n.d.). Canine and feline cutaneous round cell tumors. MSPCA-Angell. https://www.mspca.org/angell_services/canine-and-feline-cutaneous-round-cell-tumors/

Schwinn, J., Törner, K., Beitzinger, C., Klopfleisch, R., & Aupperle-Lellbach, H. (2026). The characteristics of 924 cutaneous mast cell tumours in dogs ≤ 3 years of age: With a short literature review of feline, equine, and human proliferative mast cell disorders. Veterinary Sciences, 13(5), Article 500. https://doi.org/10.3390/vetsci13050500

Torres, S. M. F. (2025). Histiocytic proliferative disorders. In Small and large animal dermatology handbook (Vol. 3). University of Minnesota Libraries Publishing. https://open.lib.umn.edu/animaldermatology3/chapter/1f-histiocytic-proliferative-disorders/

Villalobos, A. E. (2026, June). Lymphocytic, histiocytic, and related cutaneous tumors in animals. Merck Veterinary Manual. https://www.merckvetmanual.com/integumentary-system/tumors-of-the-skin-and-soft-tissues/lymphocytic-histiocytic-and-related-cutaneous-tumors-in-animals (Original full review August 2021)

Williams, K., Weir, M., & Rest, J. (n.d.). Cutaneous histiocytoma in dogs. VCA Animal Hospitals. https://vcahospitals.com/know-your-pet/skin-cutaneous-histiocytoma